Journal of Applied Physiology Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 102: 1850-1855, 2007. First published February 15, 2007; doi:10.1152/japplphysiol.01177.2006
8750-7587/07 $8.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
102/5/1850    most recent
01177.2006v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamada, T.
Right arrow Articles by Wada, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamada, T.
Right arrow Articles by Wada, M.

Myofibrillar protein oxidation and contractile dysfunction in hyperthyroid rat diaphragm

Takashi Yamada,1 Takaaki Mishima,2 Makoto Sakamoto,2 Minako Sugiyama,2 Satoshi Matsunaga,3 and Masanobu Wada1

1Graduate School of Integrated Arts and Sciences and 2Graduate School of Biosphere Science, Hiroshima University, Hiroshima; and 3Research Center for Urban Health and Sports, Osaka City University, Sugimoto, Osaka, Japan

Submitted 18 October 2006 ; accepted in final form 29 January 2007

The purpose of the present study was to test the hypothesis that administration of thyroid hormone [3,5,3'-triiodo-L-thyronine (T3)] could result in oxidation of myofibrillar proteins and, in turn, induce alterations in respiratory muscle function. Daily injection of T3 for 21 days depressed isometric forces of diaphragm fiber bundles across a range of stimulus frequencies (1, 10, 20, 40, 75, and 100 Hz) (P < 0.05). These reductions in force production were accompanied by a remarkable increment (104%; P < 0.05) in carbonyl groups of myofibrillar proteins. In contrast, T3 treatment has no effects on the carbonyl content in myosin heavy chain. In additional experiments, we have also tested the efficacy of carvedilol, a nonselective β1- β2-blocker that possesses antioxidative properties. Treatment with carvedilol dramatically improved isometric tetanic force production at stimulus frequencies from 40 to 100 Hz (P < 0.05). Carvedilol also prevented T3-induced contractile protein oxidation (P < 0.05). These data suggest that the oxidative modification of myofibrillar proteins may account, at least in part, for an impairment of diaphragm in hyperthyroidism.

reactive oxygen species; hyperthyroidism; specific force reduction; myosin heavy chain



Address for reprint requests and other correspondence: M. Wada, Graduate School of Integrated Arts and Sciences, Hiroshima Univ., 1-7-1, Higashihiroshima-shi, Hiroshima, Japan 739-8521 (e-mail: wada{at}hiroshima-u.ac.jp)




This article has been cited by other articles:


Home page
Eur Respir JHome page
F. Laghi, N. Adiguzel, and M. J. Tobin
Endocrinological derangements in COPD
Eur. Respir. J., October 1, 2009; 34(4): 975 - 996.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.